25Segments Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
25Segments General Information
Description
Developer of a drug discovery platform intended to orient medical and mechanical solutions for all aspects of the spine. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- Lengghalde 5
- 8008 Zurich
- Switzerland
Primary Industry
Drug Delivery
Corporate Office
- Lengghalde 5
- 8008 Zurich
- Switzerland
25Segments Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Stealth |
25Segments Patents
25Segments Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240245527-A1 | Expandable intervertebral cage | Active | 17-May-2021 |
25Segments Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Balgrist Beteiligungs | Venture Capital | Minority |
25Segments FAQs
-
Where is 25Segments headquartered?
25Segments is headquartered in Zurich, Switzerland.
-
What industry is 25Segments in?
25Segments’s primary industry is Drug Delivery.
-
Is 25Segments a private or public company?
25Segments is a Private company.
-
What is 25Segments’s current revenue?
The current revenue for 25Segments is .
-
Who are 25Segments’s investors?
Balgrist Beteiligungs has invested in 25Segments.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process